Section 4: Jaundice and the Breastfed Infant Flashcards
What is jaundice?
a yellow discoloration of the skin and sclera caused by hyperbilirubinemia
When does jaundice usually become visible on the sclera?
FIRST
34 to 51 μmol/L
(2-3 mg/dl)
When does jaundice become visible on the face?
68 to 86 μmol/L
( about 4 to 5 mg/dL)
Jaundice advances in a
head-to-foot direction
When does jaundice appear at the umbilicis and feet?
- umbilicus at about 258 μmol/L (15 mg/dL)
- at the feet at about 340 μmol/ (20 mg/dl)
How many neonates become visibly jaundiced in the first week of life?
Slightly more than half
Hyperbilirubinemia may be harmless or harmful depending on
its cause and the degree of elevation
The threshold for concern for jaundice varies by
- Age
- Degree of prematurity
- Health status
Jaundice threshold for healthy term infants
more than 308 μmol/L
( 18 mg/dL )
Infants who are premature, small for gestational age, or ill (sepsis, hypothermia, hypoxia) are at
much greater risk than healthy newborns
Treament for hyperbilirubinemia is given based on
- age
- clinical factors
what is the major consequence of neonatal hyperbilirubinemia
Neurotoxicity
How does neurotoxicity manifest
- acute encephalopathy
- can be followed by neuro problems eg
- cerebral palsy
- sensorimotor deficits
- cognition is usually spared
What is the most severe form of neurotoxicity
Kernicterus
Does kernicterus still occur?
Yes, although rare
What is kernicterus?
- brain damage
- Also known as Bilirubin encephalopathy
Bilirubin is normally bound to
- Serum albumin
- therfore stays in the vascular space
When can bilirubin cross the blood-brain barrier and cuase kernicterus?
WHEN ALBUMIN ISN’T KEEPING IT IN THE VASCULAR SPACE
- VERY HIGH serum bilirubin
- VERY LOW serum albumin (eg preteruM)
- BILIRUBIN displaced from Albumin (competitive binders)
What are competitive binders for bilirubin?
- drugs (eg, sulfisoxazole, ceftriaxone, aspirin)
- free fatty acids
- hydrogen ions (eg, in fasting, septic, or acidotic infants).
Risk of hyperbilirubinemia in neonates ≥ 35 weeks gestation

Patho of jaundice
- most bilirubin produced from breakdown of Hb into unconjugated bilirubin
- U. bilirubin binds to albumin in blood for transport to liver
- in liver, it is taken up by hepatocytes and conjugated (made water-soluble) by an enzyme
- Conjugated bilirubin is excreted in bile into duodenum
- In adults, Con. Bili is reduced by gut bacteria into urobilin and excreated
- Neontates have fewer gut bacteria, so excrete less bilirubin -
- they also have an enzyme that deconjugates bili
- Unconjugated bili is reabsorbed and recycled into circulation
- This is called enterohepatic circculation of bilirubin
Mechanisms of hyperbilirubinemia
- Increased production of bilirubin
- Decreased hepatic uptake
- Decreased conjugation
- Impaired excretion
- Impaired bile flow (cholestasis)
- Increased enterohepatic circulation
Most cases of jaundice involve
unconjugated hyperbilirubinemia.
What may cause a conjugated or mixed hyperbilirubinemia.
LIVER PROBLEMS
- Liver dysfunction
- neonatal sepsis
- neonatal hepatitis

